Adjuvant Chemotherapy for Resected Non-small Cell Lung Cancer
Authors:
- Christopher M. BoothCBChristopher M. Booth
- Frances A. ShepherdFSFrances A. Shepherd
- 1 February 2006
- journal article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 1 (2) , 180-187
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial1European Journal of Cardio-Thoracic Surgery, 2004
- A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304)Lung Cancer, 2004
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 2003
- Global cancer statistics in the year 2000The Lancet Oncology, 2001
- Revisions in the International System for Staging Lung CancerChest, 1997
- Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1993
- Adjuvant Chemotherapy With Cyclophosphamide, Doxorubicin, and Cisplatin in Patients With Completely Resected Stage I Non-Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 1993
- Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma.Journal of Clinical Oncology, 1986